To investigate potential cures for spinal cord injury (SCI), several researchers have transplanted neural stem/ progenitor cells (NS/PCs) into the injured spinal cord by different procedures, including intralesional (IL), intrathecal (IT), and intravenous (IV) injection. However, there are no reports quantifying or comparing the number of cells successfully transplanted to the lesion site by each procedure in vivo. The purpose of the present study was to determine the optimal method of cell transplantation to the SCI site in terms of grafted cell survival and safety. For this purpose, we developed mouse NS/PCs that expressed a novel Venusluciferase fusion protein that enabled us to detect a minimum of 1,000 grafted cells in vivo by bioluminescence imaging (BLI). After inducing contusive SCI at the T10 level in mice, NS/PCs were transplanted into the injured animals three different ways: by IL, IT, or IV injection. Six weeks after the transplantation, BLI analysis showed that in the IL group, the luminescence intensity of the grafted cells had decreased to about 10% of its initial level, and appeared at the site of injury. In the IT group, the luminescence of the grafted cells, which was distributed throughout the entire subarachnoid space immediately after transplantation, was detected at the injured site 1 week later, and by 6 weeks had gradually decreased to about 0.3% of its initial level. In the IV group, no grafted cells were detected at the site of injury, but all of these mice showed luminescence in the bilateral chest, suggesting pulmonary embolism. In addition, one third of these mice died immediately after the IV injection. In terms of grafted cell survival and safety, we conclude that the IL application of NS/PCs is the most effective and feasible method for transplanting NS/PCs into the SCI site.
INTRODUCTION
stem/progenitor cell (NS/PC) transplantation is considered one of the most promising, because the transplantation of NS/PCs into rodent SCI models (13,15,27,42, Because the adult central nervous system (CNS) has little potential for regeneration, spinal cord injury (SCI) 44, 48) and of human neural stem/progenitor cells (NS/ PCs) into a marmoset SCI model (28) have been shown usually results in severe damage, leading to paraplegia, tetraplegia, or worse. Several strategies have been used to promote functional recovery. From the viewpoint of clinical trials, it is critical to to develop new therapies that would allow patients to regain the use of their paralyzed limbs. Because cell determine how best to apply cells to the injured spinal cord. Three application methods for cell transplantation transplantation is one of the potential therapies, various kinds of cells have been used as the transplantation source for SCI are used: intralesional (IL), intrathecal (IT), and intravenous (IV). Some previous studies have sought to for SCI (14, 18, (32) (33) (34) 37, 38, 46) . Among them, neural 728 TAKAHASHI ET AL. compare different cell transplantation methods for treat-centrated virus was 1 × 10 8 to 2 × 10 8 transducing units per milliliter (TU/ml) when assayed using 293T cells, ing SCI. For example, the IL application of NS/PCs was reported to be more effective than the IT application and the infectivity was determined by fluorescence expression as analyzed on a FACS Calibur (Becton-Dick- (43) , and the IV application of NS/PCs more effective than the IL application (10). However, these reports are inson, Franklin, Lakes, NJ). not directly comparable, because they did not use the NS/PC Labeling and Differentiation Assay same number of cells for the initial transplants. Previous reports using other kinds of cells for transplantation NS/PCs were cultured as reported previously (55) . In brief, the striatum of a C57BL/6J mouse on embryonic showed that the IL application was more effective than IT or IV for introducing cells to the SCI site (7, 18, 67) , day 14 was dissociated using a fire-polished glass pipette, and the dissociated cells were collected by centrif-and that IT was more effective than IV (6,54). However, the number of cells transplanted by each method was ugation and resuspended in culture medium. The culture medium consisted of DMEM/F12 supplemented with a not quantified or compared for the different methods in vivo, and the safety of the different methods was not hormone mixture as described previously (55) . Human recombinant fibroblast growth factor-2 (FGF-2) and epi-compared. Moreover, some reports did not use uniform numbers of cells for the initial transplantation or exam-dermal growth factor (EGF) (20 ng/ml each) were added every 2 days. The cells formed floating cell clusters ine the grafted cells in vivo over the long term. Therefore, it has remained unclear which application of NS/ (neurospheres) within 2-3 days. The concentrated virus was added to the culture medium to infect primary NS/ PCs is best for injured spinal cord in terms of cell survival and safety.
PCs (multiplicity of infection, MOI = 1.0). After being propagated for two passages, the neurospheres were In the present study, to determine the best way to transplant NS/PCs into the SCI site, we applied NS/PCs used for in vivo BLI or dissociated into single cells and plated onto poly-L-ornithine-coated coverslips at a den-to the mouse injured spinal cord by IL, IT, or IV injection, and quantitatively examined the survival and distri-sity of 1 × 10 5 cells/ml for in vitro analysis. The virally transduced NS/PCs were allowed to differentiate for 5 bution of the grafted cells, as well as the complications associated with NS/PC transplantation, such as tumor days and were fixed with 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS) for immunocyto-formation and pulmonary embolism. For this purpose, we developed a new reporter gene for bioluminescence chemistry. imaging (BLI), which enabled us to quantify the biolu-SCI Model minescent signals of small numbers of cells in vivo over time.
Adult female C57BL/6J mice (20-22 g, n = 20; Clea, Tokyo, Japan) were anesthetized with an IP injection of MATERIALS AND METHODS ketamine (100 mg/kg) and xylazine (10 mg/kg). After Lentiviral Vector Expressing the ffLuc Reporter Gene laminectomy at the 10th thoracic spinal vertebra (T10), the dorsal surface of the dura matter was exposed, and A novel fusion HIV-1-based lentiviral vector, expressing ffLuc under the EF1α promoter (see Fig. 1A ) SCI was induced using a commercially available SCI device (IH impactor, Precision Systems and Instrumen-(Hara et al., in preparation), was used in this study. ffLuc is composed of Venus and Luc2: Venus is a kind tation, Lexington, KY), as described previously (47) . This device creates a reliable contusion injury by rapidly of yellow fluorescence protein (40) , Luc2 is firefly (Photinus pyralis)-derived luciferase. The luciferase applying a force-defined impact (60 kdyn) with a stainless steel-tipped impactor. All procedures were approved gene fragment was excised from the pGL4-Basic vector (Promega, Madison, WI). This vector enabled the detec-by the ethics committee of Keio University, and were in accordance with the Guide for the Care and Use of tion of grafted cells as strong bioluminescent signals from ffLuc in live SCI mice and as fluorescent signals Laboratory Animals. in spinal cord sections. Twenty-four hours before the NS/PC Transplantation transfection, 293T cells were seeded into poly-L-lysinecoated T175 flasks. The cells were transfected using the The lentivirally transduced NS/PCs were transplanted into each mouse immediately after SCI using one of the lipofection protocol for the FuGENE6 transfection reagent (Roche, Indianapolis, IN). Three days after trans-three different methods: IL cell transplantation (IL group, n = 5), IT cell transplantation (IT group, n = 5), and IV fection, the conditioned medium was collected, and the virus was concentrated by centrifugation at 25,000 rpm cell transplantation (IV group, n = 10). For the IL group, the tip of a glass micropipette was inserted into the epi-for 1.5 h at 4°C. The pelleted viral particles were resuspended and stored frozen at −80°C. The titer of the con-center of the injured spinal cord, and the NS/PCs were injected through it. For the IT group, a laminectomy was 1) (1:200; Sigma, St. Louis, MO), anti-2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) (1:200; Sigma), performed at the L3 level, and the NS/PCs were injected into the subarachnoid space at the same level, through a anti-Hu (1:1000; a gift from Dr. Robert Darnell, The Rockefeller University), and anti-APC (CC-1) (1:200; 32-gauge catheter. For the IV group, the NS/PCs were injected into the tail vein or femoral vein through a 32-Oncogene, Cambridge, MA). Hoechst 33342 was used to counterstain the nuclei (Molecular Probes, Eugene, gauge catheter. For all the applications, the number and concentration of the transplanted cells were the same (5 OR) and then samples were incubated with Alexa Fluorconjugated secondary antibodies (1:500; Molecular × 10 5 cells/2 µl), and the NS/PCs were injected at a rate of 1 µl/min with a Hamilton syringe (25 µl) and stereo-Probes, Eugene, OR). Images were obtained by fluorescence microscopy (Axiocam; Carl Zeiss, Munich, Ger-taxic microinjector (KDS 310, Muromachi-kikai, Tokyo, Japan). The number of viable cells in the suspensions many) or confocal microscopy (LSM700; Carl Zeiss). For diaminobenzidine staining, the sections were incu-was determined by cell counting using trypan blue dye and by the signal intensity of the NS/PCs determined by bated at 4°C with anti-GFP (1:500; MBL), followed by biotinylated secondary antibodies (1:500; Jackson Im-BLI prior to transplantation. munoresearch). Biotinylated antibodies were visualized Bioluminescence Imaging using the Vectastain Elite ABC kit (Vector Laboratories, Burlingame, CA), followed by diaminobenzidine (Sigma). The Xenogen-IVIS 100 cooled CCD optical macroscopic imaging system (SC BioScience, Tokyo, Japan)
Quantitative analysis of the NS/PCs after their differentiation in vitro was performed as described previously (47). (56) was used for BLI. Both in vitro and in vivo BLI was performed as previously reported (47) . In brief, the RESULTS signal intensity of the lentivirally transduced NS/PCs in In Vitro Imaging and Differentiation Assay vitro was examined on cells plated at various densities of Lentivirally Transduced NS/PCs (approximate range 1 × 10 2 to 10 6 cells/10 µl) and the bioluminescent images were captured immediately after To identify and monitor the transplanted cells, NS/ PCs were labeled by lentiviral infection with ffLuc ex-the addition of D-luciferin [D-(−)-2-(6′-hydroxy-2′-benzothiazolyl) thiazone-4-carboxylic acid] (15 mg/ml). In pressed under the EF1α promoter ( Fig. 1A ). Owing to the stable and strong emission of ffLuc, which is a fu-vivo BLIs were captured 15 min after the IP injection of D-luciferin (0.3 mg/g body weight) with the field-of-sion protein of Venus and luciferase [(39), Hara et al., in preparation] we could observe the fluorescent signals view set at 10 cm, because the photon count was most stable with its peak intensity between 10 and 30 min of the Venus by fluorescence microscopy (Fig. 1B ) and the bioluminescent signals of luciferase with BLI ( Fig.  after the IP injection of D-luciferin. The integration time was fixed at 5 min for each image. All images were ana-1C). FACS Calibur analysis revealed that >70% of these cells were positive for Venus (data not shown). The lyzed with the Igor (WaveMetrics, Lake Oswego, OR) and Living Image software (Xenogen, Alameda, CA), minimum number of cells that could be measured by their photon counts with BLI was approximately 100 and the optical signal intensity was expressed as photonflux (photon count), in units of photons/s/cm 2 /steradian. cells in vitro. There was a linear correlation between the number of labeled cells and the photon count ( Fig. 1D ). Each image was displayed as a pseudocolored photon count image superimposed on a gray scale anatomic im-
The NS/PCs expressing ffLuc showed about 10 times stronger bioluminescence intensity in vitro than the re-age. To quantify the measured light, we defined regions of interest (ROI) over the cell-implanted area and exam-ported intensity of NS/PCs expressing conventional luciferase with IRES-Venus (47) . To confirm that the len-ined all values in the same ROI. tiviral transduction did not alter the properties of the NS/ Immunohistochemistry
PCs, we performed differentiation assays on transduced NS/PCs. The transfected NS/PCs could be maintained Animals were anesthetized and transcardially perfused with 4% paraformaldehyde in 0.1 M PBS 6 weeks and passaged using the conventional neurosphere method, and an in vitro differentiation assay revealed that the after the transplantation. The spinal cord was removed, embedded in OCT compound, frozen in liquid nitrogen, trasduced NS/PCs differentiated into Tuj1-positive (21.1 ± 2.1%), GFAP-positive (50.0 ± 2.8%), and CNPase-posi-and sagittally sectioned at 30 µm on a cryostat. For immunofluorescence staining, cultured cells or tissue sec-tive (17.9 ± 8.1%) cells ( Fig. 1E-H) , which are markers for neurons, astrocytes, and oligodendrocytes, respec-tions were stained with primary antibodies, including anti-green fluorescence protein (GFP) (1:500; MBL, tively. These results showed the lentivirus-transduced NS/PCs had a similar multipotency to that reported for Woburn, MA), anti-glial fibrillary acid protein (GFAP) (1:500; AIC, Long Beach, CA), anti-β-III-tubulin (Tuj-nontransduced NS/PCs (47) . Detection Limits for In Vivo Imaging of NS/PCs cells in each mouse were measured weekly by BLI for 6 weeks after transplantation. In the IL group, the pho-Transplanted Into Intact Spinal Cord ton counts of the grafted cells were detected at the lesion When transplanted into the intact spinal cord of adult site for all 6 weeks, in spite of their decrease to approxi-C57BL/6 mice, the transfected NS/PCs showed one mately 30% of the initial level at 7 days and to 9.4 ± tenth of the photon count that was observed in vitro ( Fig.  0 .03% at 6 weeks after the transplantation (Fig. 3A, B ). 2A). There was a linear correlation between the numbers In the IT group, the grafted cells were distributed along of grafted cells and the photon count in vivo (Fig. 2B) , the entire subarachnoid space immediately after transand the minimum number of grafted cells that could be plantation, and some were detected at the lesion site 7 measured with BLI was approximately 1,000 cells (Fig. day later. The bioluminescence of the grafted cells at the 2C). As few as 100 grafted cells could be detected as lesion site gradually disappeared thereafter. The photon bioluminescence in the normal spinal cord after opening counts of the grafted cells also decreased, to about 5% the skin at the transplantation site ( Fig. 2D) .
of the initial level at 1 week and 0.3 ± 0.0%, which is almost background measurement value, at 6 weeks after In Vivo Imaging of NS/PCs Grafted Into the Injured transplantation (Fig. 3C, D) . In the IV group, no biolu-Spinal Cord minescence was detected at either the site of injury or in the uninjured spinal cord at any of the time points To examine the survival and distribution of the transplanted cells in vivo, the photon counts of the grafted examined (Fig. 3E, F) . In contrast, strong biolumines-cence was observed in the bilateral chest immediately these grafted cells differentiated into neurons, astrocytes, and oligodendrocytes within the injured spinal after the injection of the NS/PCs in all 10 animals of the IV group (Fig. 3G) , and 3 of the 10 animals died cord ( Fig. 4G-I) , as previously reported (47) . In the IT group, there were some ffLuc-positive cell clusters that immediately after the injection. In these mice, we confirmed the strong bioluminescence of the grafted cells in lay on the surface of the spinal cord ( Fig. 5A, C, D) and the cauda equina ( Fig. 5B, E, F) . These cells, which also the lung (Fig. 3H ). Although the luminescence in the bilateral chest became undetectable the next day in the differentiated into neurons, astrocytes, and oligodendrocytes ( Fig. 5G-I) , attached on the surface of pia matter surviving mice, two of the other seven mice died within 4 days of the transplantation. Five of the original 10 of the uninjured spinal cord, but not invaded into the spinal cord tissue ( Fig. 5C-F) . In the IV group, ffLuc-mice in the IV group survived for the full 6 weeks following the cell injection.
positive cells were observed in the lung and spleen, and GFP-positive fragments were found in the glomeruli of Immunohistochemistry the kidney (Fig. 6) , although no ffLuc-positive cells were detected at the lesion site. There was no tumor To examine the survival and distribution of the formation, at least 6 weeks after transplantation, in any grafted cells histologically, immunohistochemistry with of the three groups. an anti-GFP antibody, which could detect ffLuc protein, was performed 6 weeks after transplantation to identify DISCUSSION the ffLuc-positive grafted cells. Among the three groups, the IL group showed the best survival of ffLuc-positive
In the present study we used a new reporter gene, ffLuc, and BLI for the longitudinal tracking and quanti-cells at the lesion site ( Fig. 4A, B ). In the IT group, only a few grafted cells were detected at the lesion site ( Fig. fication of grafted cells in vivo. Our findings demonstrated that the IL injection of NS/PCs resulted in the 4C, D). We could not detect any grafted cells at the lesion site in the IV group (Fig. 4E, F) . In IL group, best survival of the grafted cells among the three appli- cations, and no complications were seen in the recipient owing to the tracer's short half-life and the dilution effect by cell division. MRI can detect the distribution of mouse. Our analysis also revealed the distribution of the cells transplanted by the three methods.
the transplanted cells at their initial deposition with high sensitivity, but the MRI signals from dead cells cannot To analyze the kinetics of cells after their transplantation in vivo, several previous studies have used immuno-be distinguished from those of live signals, which diminishes the usefulness of this method over time. histochemistry, gamma scintigraphic imaging (1, 11, 20, 24) , and magnetic resonance imaging (MRI) (3, 26,29, To overcome these problems, we used a BLI system, which enabled us to trace only living grafted cells in the 53). However, none of these methods permit the quantitative and continuous evaluation of the transplanted same animal at multiple time points and to quantify the bioluminescence intensity of the grafted cells as a pho-cells. Immunohistochemical analysis cannot track the fate of grafted cells in the same animal, because the ani-ton count (17, 22, 25, 35, 56, 60, 66) . Although there are previous reports in which grafted cells were analyzed by mals need to be sacrificed at serial posttransplant time points to examine the grafted cells. Scintigraphic im-BLI in injured spinal cord (33, 47) , the intensity of the bioluminescence in those studies was not strong enough aging using a radioactive tracer to label grafted cells enables the examination of their survival and distribution to detect small numbers of cells. In the present study, we used a novel fusion protein, ffLuc. NS/PCs express-in vivo, but they can only be observed for a short time, ing ffLuc emitted bioluminescent signals almost 10
From the viewpoint of clinical trials for cell transplantation to treat SCI, there is concern about causing times stronger than those of NS/PCs expressing conventional luciferase with IRES-Venus (47), thus enabling additional damage to the injured spinal cord during the cell transplantation procedure. However, several re-the detection of the bioluminescent signals of transplanted NS/PCs, even though they were present in small searchers who have performed IL cell transplantation for SCI demonstrated that motor function is not degraded number or deep inside the mouse body. Because the ffLuc that is transfected by lentivirus is expressed in the by the IL application (16) ; rather, the transplantation of cells by IL injection promotes functional recovery (19, NS/PCs permanently, we can trace the grafted NS/PCs accurately for a long period after transplantation. 30, 33, 42, 44, 47) .
The IT application is performed in two ways: one is cells adhering to the surface of the spinal cord could cause tumor formation in SCI therapy, too. by injection into the fourth ventricle (4, 45, 69, 70) and the other is by lumbar puncture (5, 21, 36) . Because the IV injection has been considered the most minimally invasive application procedure for several types of cells IT application via lumbar puncture is considered less invasive than transplantation by IL injection, this proce- (31, 61, 63) , and is already used for clinical therapies such as hematopoietic stem cell transplantation. How-dure has been used for cell transplantation into SCI patients in some hospitals (12, 59, 64) . Previous studies also ever, in the present study, the intravenously injected NS/ PCs were distributed throughout the body, and no demonstrated that grafted NS/PCs transplanted through an IT application survive within the injured spinal cord grafted cells were detected within the injured spinal cord, although some grafted cells were trapped in the (4, 36, 69) . In the present study, however, cells transplanted by IT initially dispersed throughout the entire lung, spleen, and kidney. The ffLuc-positive fragments found in the kidney were broken grafted cells. Previous subarachnoid space, resulting in low survival at the lesion site. These findings suggested that the IT applica-reports demonstrated that intravenously injected nonneural cells could be observed at a lesion site shortly after tion is an uncertain method for delivering cells to the site of injury. Moreover, a small number of the grafted the transplantation, and the mechanisms for functional recovery in this situation are thought to be trophic sup-cells survived on the surface of the uninjured spinal cord and cauda equina. Although there was no evidence of port of the grafted cells and/or activation of the intrinsic neuronal cells, rather than the displacement of lost neu-tumor formation during the observation period of this study, it was previously reported that neural cells depos-rons and glia at the lesion site, especially for mesenchymal stem cell or bone-marrow-derived stem cell trans-ited at uninjured spinal cord sites had formed enlarging clusters of cells within a couple of weeks after transplan-plantation (52, 62) . However, the important mechanisms for functional recovery from SCI are not only trophic tation (4). Furthermore, in a recent clinical procedure using an IT application, human NS/PCs caused a donor-support, but also neural circuit reconstruction, axonal induction, and remyelination (8,50,65). The cells grafted derived brain tumor in a patient with ataxia telangiectasia, which was associated with comprised immunity (2).
into the host spinal cord play a role in maintaining the improved performance. Cummings et al. showed that se-Therefore, it is highly likely that intrathecally applied Figure 6 . Immunohistochemical analysis of the several organs in the IV group. ffLuc-positive cells were found in the lung and spleen at 6 weeks after transplantation. Many ffLuc-positive fragments were also observed in the kidney, suggesting that degraded grafted cells had been trapped in the glomeruli. Scale bar: 50 µm. lective ablation of the grafted cells in the host spinal diately after the IV injection. Taken together, our findings indicate that the best method for the transplantation cord causes the deterioration of motor function (19) , indicating that the long-term survival of grafted cells in of NS/PCs into the SCI site is by IL injection, in terms of both grafted cell survival and safety of the recipient. the host spinal cord is very important for functional recovery from SCI.
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